Aplastic anaemia and telomerase RNA mutations [9]

Lancet

Volumn 360, Issue 9345, 2002, Pages 1608-

  Calado, Rodrigo T ^a   Pintão, Maria Carolina ^a   Silva Jr , Wilson A ^a   Falcão, Roberto P ^a   Zago, Marco A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE;

APLASTIC ANEMIA; BONE MARROW DEPRESSION; DRUG EXPOSURE; DYSKERATOSIS CONGENITA; GENE; GENE MUTATION; HEMATOPOIESIS; HTR GENE; HUMAN; LETTER; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TELOMERE;

EID: 0037121254     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11551-0     Document Type: Letter

References (4)

1. Vulliamy T., Marrone A., Dokal I., Mason P.J. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 359:2002;2168-2170.
2. Vulliamy T., Marrone A., Goldman F., et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 413:2001;432-435.
3. Ball S.E., Gibson F.M., Rizzo S., Tooze J.A., Marsh J.C., Gordon-Smith E.C. Progressive telomere shortening in aplastic anemia. Blood. 91:1998;3582-3592.
4. Young N.S. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol. 37:2000;3-14.